Market Drivers- Rising incidence of bone metastases: Approximately 1.5 million new cases of metastatic bone disease are reported annually in the United States alone. This rising prevalence of bone metastases is a major factor augmenting market growth. - Increasing healthcare expenditure: Growing global healthcare spending has improved access to advanced treatment procedures and drugs for...